Shufro Rose & Co’s PDL BioPharma, Inc. PDLI Stock Holding History

Shufro Rose & Co’s Portfolio PDLI Stock Details PDLI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-10,000	Closed	-$32K	–	331
2019 Q4	$32K	Hold	10,000	–	–	﹤0.01%	311
2019 Q3	$22K	Hold	10,000	–	–	﹤0.01%	324
2019 Q2	$31K	Hold	10,000	–	–	﹤0.01%	300
2019 Q1	$37K	Sell	10,000 -1,500	-13%	-$5.06K	﹤0.01%	291
2018 Q4	$33K	Hold	11,500	–	–	﹤0.01%	290
2018 Q3	$30K	Hold	11,500	–	–	﹤0.01%	292
2018 Q2	$27K	Hold	11,500	–	–	﹤0.01%	295
2018 Q1	$34K	Hold	11,500	–	–	﹤0.01%	299
2017 Q4	$32K	Hold	11,500	–	–	﹤0.01%	285
2017 Q3	$39K	Hold	11,500	–	–	﹤0.01%	286
2017 Q2	$28K	Hold	11,500	–	–	﹤0.01%	265
2017 Q1	$26K	Buy	+11,500	New	+$25.4K	﹤0.01%	270

Other funds holding PDLI

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Engine Capital Management New York $828M AUM 6.49% 1-Year Est. Return

Connor, Clark & Lunn Investment Management (CC&L)

Connor, Clark & Lunn Investment Management (CC&L) Vancouver, British Columbia, Canada $43.4B AUM 51.29% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return